Docetaxel Injection, USP, 80 mg per 8 mL (10 mg per mL), 1 x 8 mL Multi-Dose Vial, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195 (USA), Made in India. NDC 25021-254-08
Published June 19, 2024 · Recall initiated: May 28, 2024
Summary
FDA records drug Class I recall D-0553-2024, published June 19, 2024 and initiated May 28, 2024. Recalling firm: Sagent Pharmaceuticals; Status: Ongoing; Reported quantity: 762 vials; Lot: Lot #: F1040001, Exp. Date 12/31/2024. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email if DOCETAXEL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DOCETAXEL
- Manufacturer
- Sagent Pharmaceuticals
- Distributor
- Nationwide within the USA.
- Lot
- Lot #: F1040001, Exp. Date 12/31/2024
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADocetaxel Injection, USP, 160 mg per 16 mL (10 mg per mL), 1 x 16 mL Multi-Dose Vial, Rx only, Mfd. for SagentJune 19, 2024
- FDAAsmanex Twisthaler, mometasone furoate inhalation powder, 220 mcg per actuation, 30 Metered Doses, Rx Only,June 19, 2024
- FDAAsmanex Twisthaler, mometasone furoate inhalation powder, 220 mcg per actuation, 14 Metered Doses, Rx Only,June 19, 2024
- FDAIrvington Seafood Jumbo Crab Meat packaged in 1 lb plastic cups. 40 lbs casesJune 19, 2024
- FDADocetaxel Injection USP, 80 mg/4 mL, (20 mg/mL), One-Vial Formulation, Rx only, Mfd By: Dr. Reddy'sMarch 20, 2019
- FDADocetaxel injection concentrate, 20 mg/mL, 1 mL vial, Rx only, Winthrop U.S. a business of Sanofi-Aventis U.S.May 9, 2018
Questions about this recall
Was Docetaxel Injection, USP, 80 mg per 8 mL (10 mg per mL), 1 x 8 mL Multi-Dose Vial, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195 (USA), Made in India. NDC 25021-254-08 recalled?
Yes. FDA published recall D-0553-2024 on June 19, 2024. Reported hazard: Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DOCETAXEL.